Impact of Xpert MTB/RIF assay on multidrugresistant tuberculosis treatment outcomes in a health district in South Africa
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation of second-line tuberculosis (TB) treatment. However, the impact of an earlier multidrug-resistant TB (MDR-TB) diagnosis on treatment outcomes is unknown.Objectives. To compare MDR-TB treatment outcomes...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Health and Medical Publishing Group
2019-04-01
|
| Series: | South African Medical Journal |
| Online Access: | http://www.samj.org.za/index.php/samj/article/download/12571/8783 |